Invention Application
- Patent Title: COMPOSITIONS FOR PREVENTING OR TREATING COGNITIVE IMPAIRMENT-RELATED DISEASE COMPRISING MUMEFURAL
-
Application No.: US17041840Application Date: 2019-03-05
-
Publication No.: US20210106550A1Publication Date: 2021-04-15
- Inventor: Won Kyung JEON , Jihye BANG , Min Soo KIM
- Applicant: KOREA INSTITUTE OF ORIENTAL MEDICINE
- Applicant Address: KR Daejeon
- Assignee: KOREA INSTITUTE OF ORIENTAL MEDICINE
- Current Assignee: KOREA INSTITUTE OF ORIENTAL MEDICINE
- Current Assignee Address: KR Daejeon
- Priority: KR10-2018-0035324 20180327
- International Application: PCT/KR2019/002545 WO 20190305
- Main IPC: A61K31/341
- IPC: A61K31/341 ; A61K9/00 ; A61P25/28

Abstract:
The present invention relates to a composition for preventing or treating a cognitive impairment-related disease, which includes mumefural, and more particularly, to a pharmaceutical composition; a health functional food composition; and a feed composition respectively for preventing or treating a cognitive impairment-related disease; a health functional food composition for enhancing learning ability, cognitive function, or memory, each composition including mumefural or an acceptable salt thereof as an active ingredient; and a method of treating a cognitive impairment-related disease using the pharmaceutical composition.
Due to excellent effects of the mumefural of the present invention on normalizing damage to the brain (i.e., basal forebrain, white matter, hippocampus, etc.) and excellent effects thereof on enhancing memory, the mumefural of the present invention may be effectively used to treat neurodegenerative diseases (i.e., dementia, Alzheimer's disease, etc.) and cognitive impairment caused by brain damage (i.e., memory impairment), and may be used to enhance learning ability, cognitive function, and memory.
Due to excellent effects of the mumefural of the present invention on normalizing damage to the brain (i.e., basal forebrain, white matter, hippocampus, etc.) and excellent effects thereof on enhancing memory, the mumefural of the present invention may be effectively used to treat neurodegenerative diseases (i.e., dementia, Alzheimer's disease, etc.) and cognitive impairment caused by brain damage (i.e., memory impairment), and may be used to enhance learning ability, cognitive function, and memory.
Information query